Literature DB >> 23224172

Evaluation of human sclera after femtosecond laser ablation using two photon and confocal microscopy.

Hui Sun1, Ronald Kurtz, Tibor Juhasz.   

Abstract

Glaucoma is the second-leading cause of blindness worldwide and is often associated with elevated intraocular pressure (IOP). Partial thickness intrascleral channels can be created with a femtosecond laser operating at a wavelength of 1700 nm. Such channels have the potential to increase outflow facility and reduce elevated IOP. Analysis of the dimensions and location of these channels is important in understanding their effects. We describe the application of two-photon microscopy and confocal microscopy for noninvasive imaging of the femtosecond laser created partial-thickness scleral channels in human cadaver eyes. High-resolution images, hundreds of microns deep in the sclera, were obtained to allow determination of the shape and dimension of such channels. This demonstrates that concept of integrating femtosecond laser surgery, and two-photon and confocal imaging has the future potential for image-guided high-precision surgery in transparent and translucent tissue.

Entities:  

Mesh:

Year:  2012        PMID: 23224172      PMCID: PMC3381036          DOI: 10.1117/1.JBO.17.8.081411

Source DB:  PubMed          Journal:  J Biomed Opt        ISSN: 1083-3668            Impact factor:   3.170


  20 in total

Review 1.  The effect of drop vehicle on the efficacy and side effects of topical glaucoma therapy: a review.

Authors:  Richard W Yee
Journal:  Curr Opin Ophthalmol       Date:  2007-03       Impact factor: 3.761

Review 2.  Staging functional damage in glaucoma: review of different classification methods.

Authors:  Paolo Brusini; Chris A Johnson
Journal:  Surv Ophthalmol       Date:  2007 Mar-Apr       Impact factor: 6.048

3.  Mini-invasive corneal surgery and imaging with femtosecond lasers.

Authors:  Meng Han; Günter Giese; Leander Zickler; Hui Sun; Josef Bille
Journal:  Opt Express       Date:  2004-09-06       Impact factor: 3.894

4.  A quantitative analysis of transparency in the human sclera and cornea using Fourier methods.

Authors:  S Vaezy; J I Clark
Journal:  J Microsc       Date:  1991-07       Impact factor: 1.758

5.  Light propagation in tissues with controlled optical properties.

Authors:  V V Tuchin; I L Maksimova; D A Zimnyakov; I L Kon; A H Mavlyutov; A A Mishin
Journal:  J Biomed Opt       Date:  1997-10       Impact factor: 3.170

6.  3D finite element model of aqueous outflow to predict the effect of femtosecond laser created partial thickness drainage channels.

Authors:  Dongyul Chai; Gautam Chaudhary; Eric Mikula; Hui Sun; Tibor Juhasz
Journal:  Lasers Surg Med       Date:  2008-03       Impact factor: 4.025

7.  Two-photon laser scanning fluorescence microscopy.

Authors:  W Denk; J H Strickler; W W Webb
Journal:  Science       Date:  1990-04-06       Impact factor: 47.728

8.  Extent of corneal injury as a biomarker for hazard assessment and the development of alternative models to the Draize rabbit eye test.

Authors:  James V Jester
Journal:  Cutan Ocul Toxicol       Date:  2006       Impact factor: 1.820

9.  Second-harmonic imaging microscopy of normal human and keratoconus cornea.

Authors:  Naoyuki Morishige; Andrew J Wahlert; M Cristina Kenney; Donald J Brown; Koji Kawamoto; Tai-Ichiro Chikama; Teruo Nishida; James V Jester
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-03       Impact factor: 4.799

10.  Noninvasive corneal stromal collagen imaging using two-photon-generated second-harmonic signals.

Authors:  Naoyuki Morishige; W Matthew Petroll; Teruo Nishida; M Cristina Kenney; James V Jester
Journal:  J Cataract Refract Surg       Date:  2006-11       Impact factor: 3.351

View more
  1 in total

1.  Bioluminescence imaging and two-photon microscopy guided laser ablation of GBM decreases tumor burden.

Authors:  Yingwei Fan; Yu Sun; Wei Chang; Xinran Zhang; Jie Tang; Liwei Zhang; Hongen Liao
Journal:  Theranostics       Date:  2018-07-16       Impact factor: 11.556

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.